Do you want to read an article? Please log in or register.
Development and External Validation of 1- and 2- year Mortality Prediction Models in Cystic Fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
COPD
Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care
BMC Med.
Bloom CI, Ricciardi F, Smeeth L, Stone P, Quint JK
doi: 10.1186/s12916-019-1310-0.
RECOMMENDED
COPD
A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study
Chronic Obstr Pulm Dis.
Strand M, Austin E, Moll M, Pratte KA, Regan EA, Hayden LP, Bhatt SP, Boriek AM, Casaburi R, Silverman EK, Fortis S, Ruczinski I, Koegler H, Rossiter HB, Occhipinti M, Hanania NA, Gebrekristos HT, Lynch DA, Kunisaki KM, Young KA, Sieren JC, Ragland M, Hokanson JE, Lutz SM, Make BJ, Kinney GL, Cho MH, Pistolesi M, DeMeo DL, Sciurba FC, Comellas AP, Diaz AA, Barjaktarevic I, Bowler RP, Kanner RE, Peters SP, Ortega VE, Dransfield MT, Crapo JD
doi: 10.15326/jcopdf.7.4.2020.0146.
RECOMMENDED
Pulmonary Fibrosis
Safety, pharmacokinetics, and pharmacodynamics of lumacaftor and ivacaftor combination therapy in children aged 2-5 years with cystic fibrosis homozygous for F508del-CFTR: an open-label phase 3 study
Lancet Respir Med.
McNamara JJ, McColley SA, Marigowda G, Liu F, Tian S, Owen CA, Stiles D, Li C, Waltz D, Wang LT, Sawicki GS
doi: 10.1016/S2213-2600(18)30460-0.
Pulmonary Fibrosis
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Lancet Respir Med.
Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N
doi: 10.1016/
Pulmonary Fibrosis
Validation of automated lobe segmentation on paired inspiratory-expiratory chest CT in 8-14 year-old children with cystic fibrosis
PLoS One.
Konietzke P, Weinheimer O, Wielpütz MO, Savage D, Ziyeh T, Tu C, Newman B, Galbán CJ, Mall MA, Kauczor HU, Robinson TE
doi: 10.1371/journal.pone.0194557
RECOMMENDED
COPD
A Risk Prediction Model for Mortality Among Smokers in the COPDGene® Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chronic Obstr Pulm Dis
Strand M, Austin E, Moll M, Pratte KA, Regan EA, Hayden LP, Bhatt SP, Boriek AM, Casaburi R, Silverman EK, Fortis S, Ruczinski I, Koegler H, Rossiter HB, Occhipinti M, Hanania NA, Gebrekristos HT, Lynch DA, Kunisaki KM, Young KA, Sieren JC, Ragland M, Hokanson JE, Lutz SM, Make BJ, Kinney GL, Cho MH, Pistolesi M, DeMeo DL, Sciurba FC, Comellas AP, Diaz AA, Barjaktarevic I, Bowler RP, Kanner RE, Peters SP, Ortega VE, Dransfield MT, Crapo JD
doi: 10.15326/jcopdf.7.4.2020.0146
Interstitial Lung Disease
Outcomes and mortality prediction model of critically ill adults with acute respiratory failure and interstitial lung disease
Chest.
Gannon W, Lederer DJ, Biscotti M, Javaid A, Patel N, Brodie D, Bacchetta M, Baldwin M
doi: 10.1016/j.chest.2018.01.006.
Pulmonary Fibrosis
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicenter observational study
Eur Respir J.
Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, Vancheri C
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Fibrosis
Validation of the French 3-year prognostic score for death or lung transplant in the United States cystic fibrosis population
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Ramos KJ, Wai TH, Sykes J, Ma X, Stephenson AL, Jennerich AL, Kapnadak SG, Mayer-Hamblett N, Goss CH
doi: 10.1016/j.jcf.2021.08.008